Kelena S Klippel,
GRADUATE AST-R
Department:
MD-ANESTHESIOLOGY-GENERAL
Business Phone:
(352) 328-1268
Business Email:
coffeelocks@ufl.edu
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-7524-2448
Publications
2024
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade.
Nature communications.
15(1)
[DOI] 10.1038/s41467-024-49989-1.
[PMID] 38997283.
2024
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors.
Genome medicine.
16(1)
[DOI] 10.1186/s13073-024-01281-z.
[PMID] 38268001.
2023
CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade.
Research square.
[DOI] 10.21203/rs.3.rs-3463730/v1.
[PMID] 38014191.
2023
Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
Clinical Cancer Research.
29(9):1751-1762
[DOI] 10.1158/1078-0432.ccr-22-1682.
2020
Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice.
Proceedings of the National Academy of Sciences of the United States of America.
117(31):18591-18599
[DOI] 10.1073/pnas.2005748117.
[PMID] 32690681.
Grants
Sep 2022
– Aug 2023
IPA Kelena Klippel 2022-2023
Role: Principal Investigator
Funding: US DEPT OF VET AFF GAINESVILLE MED CTR
Contact Details
Phones:
- Business:
- (352) 328-1268
Emails:
- Business:
- coffeelocks@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100254
GAINESVILLE FL 32610 - Business Street:
-
1345 CENTER DR
GAINESVILLE FL 32611